The positive market sentiment in 2024 has been dampened by several macro indicators which slowed down in Q1/2025, according to a Savills report. The government’ ...

Chandigarh: In a significant move to strengthen healthcare delivery at the grassroots level, the Punjab health department has ...

GEN2 is well tolerated with minimal toxicity and signs of pharmacodynamic activity in an ongoing Phase 1 dose escalation and ...

Ballarat Highway Patrol officers along with the National Heavy Vehicle regulator were inspecting trucks and their drivers as ...

Microorganisms generate all sorts of materials that could serve as potential agents for combating bacteria and fungi. An ...

Gene therapy is at the cutting edge of medicine, with exciting new products being developed and used to treat a wide variety ...

AAVantgarde Bio (AAVantgarde), a clinical-stage international biotechnology company with two proprietary Adeno-Associated Viral (AAV) vector platforms for large gene delivery, today announces the ...

EnGeneIC Pty Ltd, a Sydney-based biotechnology company and leader in innovative cancer therapies, has announced the successful dosing of the first patient in its open-label, multicentre, Phase I/IIa ...

The authors confirm that telomeres in telomerase-positive cells terminate with 5'-ATC in a Pot1-dependent manner, and demonstrate that this principle holds true in telomerase-negative ALT cells as ...

According to a Savills report, drawing confidence from government efforts to build a favorable environment, investment sentiment appears to be positive. During ...

Japan Tobacco Inc. ( OTCPK:JAPAY) Q1 2025 Results Conference Call May 7, 2025 6:00 AM ET Hiromasa Furukawa - Group Chief Financial Officer Dinesh Babu Thotakura - General Manager Nobuya Kato - JTI ...

The scope of the presented studies is somewhat limited, as they primarily focus on evaluating the phenotypic changes in cardiac innervation following the loss of various Slit or Robo genes.